Mounjaro (tirzepatide) is an FDA-approved medication for type 2 diabetes. It works by targeting two receptors: GLP-1 and GIP, both of which help regulate blood sugar, slow digestion, and reduce appetite.
Though not yet FDA-approved for weight loss, Mounjaro is frequently prescribed off-label for that purpose. Many clinical studies show that Mounjaro may produce more significant weight loss than other GLP-1 drugs, including Ozempic.
What Is Ozempic?
Ozempic (semaglutide) is also a once-weekly injectable drug originally approved for type 2 diabetes. It targets the GLP-1 receptor and helps with blood sugar control, reduced appetite, and gradual weight loss. Ozempic’s active ingredient (semaglutide) is also found in Wegovy, which is FDA-approved for weight loss.
Mounjaro vs Ozempic: Weight Loss Results
In head-to-head comparisons, Mounjaro has shown greater average weight loss than Ozempic at similar or even lower doses. Clinical data includes:
Mounjaro: Up to 20% total body weight loss at higher doses (15 mg)
Ozempic: Average of 10–15% total weight loss at maximum doses
This has made Mounjaro the subject of strong interest among those seeking the best weight loss injection, especially when Ozempic results plateau.
Dosing and Administration
Medication | Frequency | Starting Dose | Maximum Dose |
---|---|---|---|
Ozempic | Weekly | 0.25 mg | 2.0 mg |
Mounjaro | Weekly | 2.5 mg | 15 mg |
Both are self-administered using pre-filled injection pens. Doses are gradually increased over several weeks to reduce side effects.
Cost Comparison: Mounjaro vs Ozempic
Medication | Retail Cost (U.S.) | Coupon Options | Insurance Coverage |
---|---|---|---|
Ozempic | ~$900/month | Manufacturer savings card, GoodRx | Often covered with PA |
Mounjaro | ~$1,100/month | Lilly Savings Card, telehealth plans | Coverage varies |
Without insurance, Ozempic is slightly less expensive, but Mounjaro coupons can significantly reduce out-of-pocket costs for eligible patients (as low as $25/month for some with insurance).